Strongbridge Biopharma doses first four patients in LOGICS, a second global Phase 3 study of RECORLEV in endogenous CS (Apr-2018) https://t.co/fmeSbsTZpB
American Academy of Family Physicians, Zipnosis Announce Strategic Partnership to Provide Virtual Care Solution for Family Physicians https://t.co/wYlU9oH8SY
Cellectis and Allogene Therapeutics Intend to Continue Strategic Cancer Immunotherapy Collaboration to Accelerate Development and Commercialization of Allogeneic Off-the-Shelf CAR T Therapies https://t.co/Nw6pjPlY7y
Bicycle Therapeutics to Present New BT1718 Data in the "New Drugs on the Horizon" Session at the 2018 American Association for Cancer Research Meeting https://t.co/3LDt96Eyfx